ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 67 filers reported holding ADICET BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,186 | -62.6% | 6,705 | -33.7% | 0.00% | – |
| Q2 2023 | $24,565 | -84.9% | 10,109 | -64.1% | 0.00% | – |
| Q1 2023 | $162,259 | -34.6% | 28,170 | +1.5% | 0.00% | – |
| Q4 2022 | $248,112 | -34.5% | 27,753 | +4.1% | 0.00% | -100.0% |
| Q3 2022 | $379,000 | -4.8% | 26,662 | -2.3% | 0.00% | 0.0% |
| Q2 2022 | $398,000 | +80.9% | 27,280 | +147.5% | 0.00% | – |
| Q1 2022 | $220,000 | +11.7% | 11,022 | -1.9% | 0.00% | – |
| Q4 2021 | $197,000 | +123.9% | 11,240 | 0.0% | 0.00% | – |
| Q3 2021 | $88,000 | -70.4% | 11,240 | -61.0% | 0.00% | – |
| Q2 2021 | $297,000 | – | 28,847 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |